ZA200804492B - S-Omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same - Google Patents

S-Omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Info

Publication number
ZA200804492B
ZA200804492B ZA200804492A ZA200804492A ZA200804492B ZA 200804492 B ZA200804492 B ZA 200804492B ZA 200804492 A ZA200804492 A ZA 200804492A ZA 200804492 A ZA200804492 A ZA 200804492A ZA 200804492 B ZA200804492 B ZA 200804492B
Authority
ZA
South Africa
Prior art keywords
same
hydrate
pharmaceutical composition
omeprazole strontium
preparing
Prior art date
Application number
ZA200804492A
Other languages
English (en)
Inventor
Ha Tae Hee
Oh Hee Sook
Kim Won Jeoung
Park Chang Hee
Kim Eun Young
Kim Young Hoon
Kwee-Hyun Suh
Lee Gwan Sun
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of ZA200804492B publication Critical patent/ZA200804492B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200804492A 2005-10-26 2006-10-25 S-Omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same ZA200804492B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20050101059 2005-10-26

Publications (1)

Publication Number Publication Date
ZA200804492B true ZA200804492B (en) 2009-08-26

Family

ID=37872502

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804492A ZA200804492B (en) 2005-10-26 2006-10-25 S-Omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Country Status (10)

Country Link
US (4) US7576219B2 (es)
EP (2) EP2269999B1 (es)
KR (2) KR100818753B1 (es)
CN (1) CN101296921B (es)
BR (1) BRPI0617879A2 (es)
ES (1) ES2390848T3 (es)
HK (1) HK1104035A1 (es)
NZ (1) NZ568412A (es)
UA (1) UA86335C2 (es)
ZA (1) ZA200804492B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576219B2 (en) * 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
WO2009074997A2 (en) * 2007-12-10 2009-06-18 Lee Pharma Ltd. A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate
CN102887885B (zh) * 2012-09-26 2014-12-10 江苏正大丰海制药有限公司 一种埃索美拉唑钠的制备方法
CN102964335B (zh) * 2012-11-13 2014-06-25 凌元敏 一种埃索美拉唑钠化合物及其制备方法和用途
CN103044400A (zh) * 2012-12-21 2013-04-17 北京华禧联合科技发展有限公司 埃索美拉唑镁盐及其制备方法
CN105853419B (zh) * 2016-06-10 2018-11-20 江苏食品药品职业技术学院 一种用于胃溃疡治疗的药物组合物及其应用
CN107773529B (zh) * 2016-08-24 2020-06-16 华仁药业股份有限公司 一种埃索美拉唑钠氯化钠注射液及其制备方法
CN110526899A (zh) * 2018-05-24 2019-12-03 刘力 埃索美拉唑锶新化合物及其药物组合物和用途
KR102197144B1 (ko) 2019-03-29 2021-01-05 유한회사 더프라임솔루션 아킹현상을 방지하는 저온 플라즈마 배출가스 입자상 물질 저감 장치
KR102249552B1 (ko) 2020-06-16 2021-05-12 (주)에미션컨트롤스탠다드 저온 플라즈마를 이용한 실내외 대기 중 또는 배출가스 내 오염물질 저감장치

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
US5877192A (en) 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
DE60314105T2 (de) 2002-03-05 2008-01-24 Astrazeneca Ab Alkylammoniumsalze von omeprazol und esomeprazol
WO2004099182A1 (en) 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
SI1651217T1 (sl) 2003-07-23 2008-08-31 Nycomed Gmbh Alkalne soli inhibitorjev protonske ÄŤrpalke
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
KR100598261B1 (ko) 2003-12-30 2006-07-07 동부일렉트로닉스 주식회사 노광기의 웨이퍼 외곽 포커싱 장치
KR20080007508A (ko) 2005-05-06 2008-01-21 그렌마크 파머수티칼스 엘티디. 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물
US7576219B2 (en) * 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
JP5017274B2 (ja) 2005-10-26 2012-09-05 ハンミ・サイエンス・カンパニー・リミテッド Ｓ−オメプラゾールストロンチウム塩またはその水和物、その製造方法、及びこれを含む医薬組成物

Also Published As

Publication number Publication date
CN101296921A (zh) 2008-10-29
US20090258908A1 (en) 2009-10-15
EP2269999A1 (en) 2011-01-05
US20070093533A1 (en) 2007-04-26
US20110046383A1 (en) 2011-02-24
EP2269999B1 (en) 2016-03-02
US8586752B1 (en) 2013-11-19
US8106076B2 (en) 2012-01-31
ES2390848T3 (es) 2012-11-19
EP1780207A2 (en) 2007-05-02
BRPI0617879A2 (pt) 2011-08-09
EP1780207B1 (en) 2012-08-15
KR20080015483A (ko) 2008-02-19
CN101296921B (zh) 2012-07-18
NZ568412A (en) 2010-11-26
UA86335C2 (uk) 2009-04-10
US8513426B2 (en) 2013-08-20
US7576219B2 (en) 2009-08-18
US20130303772A1 (en) 2013-11-14
EP1780207A3 (en) 2007-07-04
HK1104035A1 (en) 2008-01-04
KR20070045101A (ko) 2007-05-02
KR100818753B1 (ko) 2008-04-01

Similar Documents

Publication Publication Date Title
ZA200804492B (en) S-Omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
IL214183A (en) Pharma-informatics system and method, preparation for use with it and method for preparation of the preparation
EP2114904A4 (en) TRIAZOLE DERIVATIVES WITH ANTIPILY EFFECT, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL210756A0 (en) Carbostyril compound, process for their preparation and pharmaceutical compositions containing them
IL186523A0 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
EP1965816A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING OR PREVENTING OXALATE-ASSOCIATED DISEASE
HK1123789A1 (en) Azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
IL183923A0 (en) Process for preparing voriconazole and voriconazole prepared thereby
HK1112916A1 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof 3-
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
ZA200801896B (en) Slow-release composition, method for the preparation thereof, and use of the same
HK1098482A1 (en) Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
EP2201011A4 (en) NEW COMPOUNDS WITH INDAZOUS OUTS, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
IL186062A (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
PL2059503T3 (pl) Pochodne aminopirazolu, sposób ich wytwarzania oraz kompozycja do zapobiegania lub leczenia chorób niedokrwiennych zawierająca takie pochodne
PL1655030T3 (pl) Pochodne benzotiadiazyny, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
IL184488A0 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
EP2144896A4 (en) CRYSTALLINE BEPOTASTIN METAL SALT HYDRATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAID HYDRATE
EP2163244A4 (en) MEDIUM, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING THE DEPENDENCE OF ETHYL ALCOHOL OR NARCOTICS
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
ZA200900231B (en) (S)-(-)-amlodipine camsylate or hydrate thereof and pharmaceutical composition comprising same